Diaceutics (DXRX) Stock Chart & Stock Price History GBX 119 -1.00 (-0.83%) (As of 11/15/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades Diaceutics Stock Price Performance 5 Day Performance-2.06%1 Month Performance-10.53%3 Month Performance-4.03%6 Month Performance+3.93%Year-To-Date Performance+36.78%1 Year Performance+33.71% Receive DXRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter. Email Address The Crypto That’s Making Wall Street Sweat (Ad)The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.Click here to discover our #1 crypto for the market right now – poised for massive growth DXRX Stock Chart for Sunday, November, 17, 2024 DXRX Chart by TradingView Diaceutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/15/2024GBX 118.08GBX 118-0.07%GBX 120GBX 1184,000 shs£99.68 million11/14/2024GBX 121.40GBX 118.08-2.73%GBX 120.86GBX 118.08103,894 shs£99.74 million11/13/2024GBX 121.50GBX 121.40-0.08%GBX 121.40GBX 12010,376 shs£102.55 million11/12/2024GBX 120.80GBX 121.50+0.58%GBX 121.70GBX 1205,264 shs£102.63 million11/11/2024GBX 121.50GBX 120.80-0.58%GBX 122GBX 12069,551 shs£102.04 million11/08/2024GBX 121.50GBX 120.56-0.77%GBX 122GBX 120.1059,682 shs£101.84 million Get the Latest News and Ratings for DXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter. 11/07/2024GBX 121.50GBX 121.50GBX 122.14GBX 120.562,231 shs£102.63 million11/06/2024GBX 120GBX 121.50+1.25%GBX 121.50GBX 12016,962 shs£102.63 million11/05/2024GBX 122GBX 120-1.64%GBX 121.33GBX 12016,964 shs£101.36 million11/04/2024GBX 121.50GBX 122+0.41%GBX 122.14GBX 120.5034,041 shs£103.05 million11/01/2024GBX 121.50GBX 120-1.23%GBX 121.50GBX 12044,747 shs£101.36 million10/31/2024GBX 121.50GBX 121.50GBX 122GBX 121.50156,897 shs£102.63 million10/30/2024GBX 118GBX 121.50+2.97%GBX 122.85GBX 117.80192,229 shs£102.63 million10/29/2024GBX 120GBX 118-1.67%GBX 122.50GBX 11833,995 shs£99.68 million10/28/2024GBX 123.50GBX 120-2.83%GBX 123.90GBX 12048,977 shs£101.36 million10/25/2024GBX 126GBX 123.50-1.98%GBX 126.56GBX 122.0624,512 shs£104.32 million10/24/2024GBX 127GBX 126-0.79%GBX 131GBX 12551,701 shs£106.43 million10/23/2024GBX 129GBX 127-1.55%GBX 131GBX 1275,782 shs£107.28 million10/22/2024GBX 132GBX 129-2.27%GBX 130.25GBX 12920,000 shs£108.97 million10/21/2024GBX 133GBX 132-0.75%GBX 133.50GBX 13155,445 shs£111.50 million10/18/2024GBX 133GBX 132-0.75%GBX 134GBX 13274,482 shs£111.50 million10/17/2024GBX 134GBX 133-0.75%GBX 133.50GBX 13316,920 shs£112.35 million10/16/2024GBX 134GBX 134GBX 134GBX 13055,624 shs£113.19 million Related Companies ANGLE Stock Chart Abingdon Health Stock Chart genedrive Stock Chart Verici Dx Stock Chart Proteome Sciences Stock Chart GENinCode Stock Chart LungLife AI Stock Chart Integrated Diagnostics Stock Chart LLA.L,0P0001T9GN,0 Stock Chart MaxCyte Stock Chart Receive DXRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:DXRX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Diaceutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Diaceutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DXRX Stock Alerts